Amarin Corp Plc (AMRN)

[sts66]

EVAPORATE may not elevate the pps next week, but it will definitely elevate sales if V is shown to reduce plaque - doctors will understand that V can reverse CVD and may prevent the first CVE, meaning it's important if we don't get primary prevention on the label. EU is in no way baked in IMO - haven't even filed the application yet, and it's a bigger market than the US - your $35-$40 estimate would likely get rejected by investors unless the Baker Bros and a couple other big holders support a BO at that price - at $40 the BB's stake would be worth close to $2B and be in their top 3 holdings.